Skip to main content
logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
16.78
+0.06 (0.36%)
Jun 1, 2026, 1:42 PM EDT - Market open

Caris Life Sciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
33.98-68.09-281.89-341.42-320.83
Depreciation & Amortization
20.6422.6248.914948.25
Stock-Based Compensation
71.1970.0118.6415.2422.9
Other Adjustments
48.3791.75-1.88.2-13.78
Change in Receivables
-16.08-29.79-33.82-15.08-11.91
Changes in Inventories
-36.14-20.755.46-4.44-11.1
Changes in Accounts Payable
29.1511.04-0.237.178.91
Changes in Accrued Expenses
-6.0811.480.81.26-6.6
Changes in Other Operating Activities
-9.01-5.1-1.293.96-1.56
Operating Cash Flow
147.3783.16-245.2-276.1-285.71
Capital Expenditures
-23.91-16.26-8.44-22.32-42.26
Purchases of Investments
----63.4-378.38
Proceeds from Sale of Investments
--61.38300.49137.65
Investing Cash Flow
-9.13-16.2652.93214.77-282.99
Long-Term Debt Issued
13.9327.87199.98191.31-
Long-Term Debt Repaid
----180-
Net Long-Term Debt Issued (Repaid)
13.9327.87199.9811.31-
Issuance of Common Stock
271.35536.11.531.8711.41
Repurchase of Common Stock
-18.7-18.66---
Net Common Stock Issued (Repurchased)
252.66517.431.531.8711.41
Issuance of Preferred Stock
60.62121.24---
Net Preferred Stock Issued (Repurchased)
60.62121.24---
Other Financing Activities
-4.59-1.55-1.22-3.04-0.96
Financing Cash Flow
664.53664.99200.2910.1310.45
Effect of Exchange Rate Changes on Cash and Cash Equivalents
0.120.13-00.060
Net Cash Flow
788.1732.018.02-51.13-558.25
Free Cash Flow
123.4666.9-253.64-298.42-327.96
Free Cash Flow Growth
84.55%----
FCF Margin
13.61%8.24%-61.52%-97.48%-126.88%
Free Cash Flow Per Share
0.520.40-7.15-8.54-9829.27
Levered Free Cash Flow
-12.45-37.21-133.06-416.58-325.18
Unlevered Free Cash Flow
82.5648.13-211.9-284.92-320.11
SEC Filings: 10-K · 10-Q